PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2010 2011 2012
Boston University, with its local partner Health Economics and Epidemiology Research Office (HE2RO) of the University of the Witwatersrand, generate accurate, current, program-relevant information about the outcomes, costs, cost-effectiveness, and benefits of HIV/AIDS and TB prevention, care, and treatment interventions. The project includes evaluations in five main areas: 1. Estimating the costs and cost-effectiveness of adult and pediatric HIV treatment delivery2. National modeling of the costs of HIV care and treatment and PMTCT3. Reducing loss to pre-ART care and promoting earlier treatment initiation4. Improving treatment outcomes through epidemiological analysis of PEPFAR partner data5. Economic evaluation and modeling of TB and HIV/TB integration (case finding, diagnosis, treatment)Each of these areas is a priority under Pillars 1 and 2 of the NSP and the Partnership Framework principles of sustainability, innovation, and responsiveness, as they focus on generating the knowledge base needed to identify efficient ways to deliver services, achieve health targets at the lowest cost, and ensure value for money. The project directly supports the SAG in improving budgeting and resource allocation. The project also strengthens decentralization and integration of health services by evaluating the outcomes and costs of different models of service delivery (e.g. nurse-managed HIV treatment and use of point-of-care TB diagnostics and CD4 tests).
The budget will be divided among the five technical areas of work described in the Overview Narrative as follows:
1. Cost and cost-effectiveness of HIV treatment delivery: $107,9382. Modeling of treatment costs: $43,1753. Loss to pre-ART care/earlier treatment initiation: $107,9384. Improving treatment outcomes: $43,1755. Economics of TB: $129,527
All of these activities involve tracking and evaluating clinical outcomes, improving program performance, and increasing efficiency of service delivery. Area 3 specifically addresses efforts to improve the transition to care and retention of patients in pre-ART care, while Area 4 generates information about retention and adherence after ART initiation. Area 5 pertains to the development of a comprehensive package of care that includes TB screening, diagnosis, and treatment. Areas 1 and 2 are aimed at generating site-level and national data to improve access to services and the sustainability of service delivery and to strengthen local ownership.
